SPR-202

N/A

Report date: 2026/01/30 16:42:39

Base Information

Drug NameSPR-202
Drug Alias NameHAT-001HBM9013HBM-9013SPR-202SPR202
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionAnti-Corticotropin-releasing hormone
TargetsCorticotropin-releasing hormone
Therapy Area/IndicationsAdrenal Hyperplasia, Congenital
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesHBM Alpha Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesHBM Alpha Therapeutics IncSpruce Biosciences Inc
Inactive CompaniesN/A
Active IndicationsAdrenal Hyperplasia, Congenital
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A